News
The New England Journal of Medicine has just published the primary results of an ongoing phase IIb clinical trial testing the candidate tuberculosis vaccine M72/AS01E which demonstrates that the M72/AS01E vaccine significantly reduced the incidence of pulmonary tuberculosis disease in HIV-negative adults who were already infected with latent TB at the time of vaccination.
SATVI Researcher Marwou de Kock has co-authored a research article titled: "PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis" appearing in the Frontiers in Immunology journal.
SATVI Associate Professor Tom Scriba has co-authored a research paper titled "Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination" appearing in the Scientific Reports journal.
SATVI and the Western Department of Education are pleased to announce the hosting of the Kick TB Poster Art and Writing Exhibit on Monday 3 September 2018.
Pages
SATVI Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
GPS coordinates -33.620455, 19.458576
Map to Worcester Field Office